Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker CADL
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 12, 2026 | CADL Candel Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 12, 2026 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 10, 2026 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 10, 2026 | CADL Candel Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Sep 9, 2026 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 13, 2026 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 24, 2026 | CADL Candel Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 16, 2026 | CADL Candel Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 15, 2026 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 14, 2026 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 12, 2026 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 23, 2026 | CADL Candel Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 23, 2026 | CADL Candel Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 19, 2026 | CADL Candel Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 19, 2026 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 19, 2026 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 19, 2026 | CADL Candel Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 5, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 13, 2025 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 14, 2025 | CADL Candel Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 14, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 14, 2025 | CADL Candel Therapeutics, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 14, 2025 | CADL Candel Therapeutics, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Oct 14, 2025 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 14, 2025 | CADL Candel Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 21, 2025 | CADL Candel Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 14, 2025 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 24, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 24, 2025 | CADL Candel Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 23, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 23, 2025 | CADL Candel Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jun 18, 2025 | CADL Candel Therapeutics, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 6, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 6, 2025 | CADL Candel Therapeutics, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 28, 2025 | CADL Candel Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 28, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 22, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| May 13, 2025 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 23, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 27, 2025 | CADL Candel Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 27, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Mar 13, 2025 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 25, 2025 | CADL Candel Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 25, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2025 | CADL Candel Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 13, 2025 | CADL Candel Therapeutics, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jan 13, 2025 | CADL Candel Therapeutics, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 13, 2024 | CADL Candel Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 13, 2024 | CADL Candel Therapeutics, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 11, 2024 | CADL Candel Therapeutics, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 4:47 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances